• Je něco špatně v tomto záznamu ?

Uric acid modulates vascular endothelial function through the down regulation of nitric oxide production

I. Papežíková, M. Pekarová, H. Kolářová, A. Klinke, D. Lau, S. Baldus, A. Lojek, L. Kubala,

. 2013 ; 47 (2) : 82-8.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc13024176

Endothelial dysfunction characterized by decreased nitric oxide (NO) bioavailability is the first stage of coronary artery disease. It is known that one of the factors associated with an increased risk of coronary artery disease is a high plasma level of uric acid. However, causative associations between hyperuricaemia and cardiovascular risk have not been definitely proved. In this work, we tested the effect of uric acid on endothelial NO bioavailability. Electrochemical measurement of NO production in acetylcholine-stimulated human umbilical endothelial cells (HUVECs) revealed that uric acid markedly decreases NO release. This finding was confirmed by organ bath experiments on mouse aortic segments. Uric acid dose-dependently reduced endothelium-dependent vasorelaxation. To reveal the mechanism of decreasing NO bioavailability we tested the effect of uric acid on reactive oxygen species production by HUVECs, on arginase activity, and on acetylcholine-induced endothelial NO synthase phosphorylation. It was found that uric acid increases arginase activity and reduces endothelial NO synthase phosphorylation. Interestingly, uric acid significantly increased intracellular superoxide formation. In conclusion, uric acid decreases NO bioavailability by means of multiple mechanisms. This finding supports the idea of a causal association between hyperuricaemia and cardiovascular risk.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13024176
003      
CZ-PrNML
005      
20130711091449.0
007      
ta
008      
130703s2013 enk f 000 0|eng||
009      
AR
024    7_
$a 10.3109/10715762.2012.747677 $2 doi
035    __
$a (PubMed)23136942
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Papežíková, I $u Department of Free Radical Patophysiology, Institute of Biophysics, v. v. i., Academy of Sciences of the Czech Republic, and International Clinical Research Center-Center of Biomolecular and Cellular Engineering, St. Anne's University Hospital Brno, Kralovopolska 135, Brno, Czech Republic. papezikovai@email.cz
245    10
$a Uric acid modulates vascular endothelial function through the down regulation of nitric oxide production / $c I. Papežíková, M. Pekarová, H. Kolářová, A. Klinke, D. Lau, S. Baldus, A. Lojek, L. Kubala,
520    9_
$a Endothelial dysfunction characterized by decreased nitric oxide (NO) bioavailability is the first stage of coronary artery disease. It is known that one of the factors associated with an increased risk of coronary artery disease is a high plasma level of uric acid. However, causative associations between hyperuricaemia and cardiovascular risk have not been definitely proved. In this work, we tested the effect of uric acid on endothelial NO bioavailability. Electrochemical measurement of NO production in acetylcholine-stimulated human umbilical endothelial cells (HUVECs) revealed that uric acid markedly decreases NO release. This finding was confirmed by organ bath experiments on mouse aortic segments. Uric acid dose-dependently reduced endothelium-dependent vasorelaxation. To reveal the mechanism of decreasing NO bioavailability we tested the effect of uric acid on reactive oxygen species production by HUVECs, on arginase activity, and on acetylcholine-induced endothelial NO synthase phosphorylation. It was found that uric acid increases arginase activity and reduces endothelial NO synthase phosphorylation. Interestingly, uric acid significantly increased intracellular superoxide formation. In conclusion, uric acid decreases NO bioavailability by means of multiple mechanisms. This finding supports the idea of a causal association between hyperuricaemia and cardiovascular risk.
650    _2
$a acetylcholin $x farmakologie $7 D000109
650    _2
$a zvířata $7 D000818
650    _2
$a arginasa $x metabolismus $7 D001119
650    _2
$a buněčné linie $7 D002460
650    _2
$a nemoci koronárních tepen $x metabolismus $7 D003324
650    _2
$a down regulace $7 D015536
650    _2
$a cévní endotel $x metabolismus $7 D004730
650    _2
$a endoteliální buňky pupečníkové žíly (lidské) $7 D061307
650    _2
$a lidé $7 D006801
650    _2
$a hyperurikemie $x metabolismus $7 D033461
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a oxid dusnatý $x biosyntéza $x metabolismus $7 D009569
650    _2
$a synthasa oxidu dusnatého, typ III $x metabolismus $7 D052250
650    _2
$a fosforylace $7 D010766
650    _2
$a reaktivní formy kyslíku $x chemie $x metabolismus $7 D017382
650    _2
$a superoxidy $x metabolismus $7 D013481
650    _2
$a kyselina močová $x krev $x chemie $x metabolismus $7 D014527
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pekarová, M $u -
700    1_
$a Kolářová, H $u -
700    1_
$a Klinke, A $u -
700    1_
$a Lau, D $u -
700    1_
$a Baldus, S $u -
700    1_
$a Lojek, A $u -
700    1_
$a Kubala, L $u -
773    0_
$w MED00007947 $t Free radical research $x 1029-2470 $g Roč. 47, č. 2 (2013), s. 82-8
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23136942 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20130703 $b ABA008
991    __
$a 20130711091914 $b ABA008
999    __
$a ok $b bmc $g 987856 $s 822556
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 47 $c 2 $d 82-8 $i 1029-2470 $m Free radical research $n Free Radic Res $x MED00007947
LZP    __
$a Pubmed-20130703

Najít záznam

Citační ukazatele

Možnosti archivace